Drugs / veneclax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06827899 | Jul 2022 → Jun 2026 overdue | acute myeloid leukemia | The First Affiliated Hospital of Xiamen University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | veneclax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06827899 ↗ |